Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria

被引:528
作者
Nykamp, Keith [1 ]
Anderson, Michael [1 ]
Powers, Martin [1 ]
Garcia, John [1 ]
Herrera, Blanca [1 ]
Ho, Yuan-Yuan [1 ]
Kobayashi, Yuya [1 ]
Patil, Nila [1 ]
Thusberg, Janita [1 ]
Westbrook, Marjorie [1 ]
Topper, Scott [1 ]
机构
[1] Invitae Corp, San Francisco, CA 94103 USA
关键词
ACMG laboratory guideline; clinical genetic testing; clinical interpretation; variant classification; variant interpretation; NONPOLYPOSIS COLORECTAL-CANCER; AUSTRALIAN MELANOMA KINDREDS; HYPERTROPHIC CARDIOMYOPATHY; E-CADHERIN; FUNCTIONAL-ANALYSIS; MISSENSE MUTATIONS; CDKN2A MUTATIONS; GENETIC-VARIANTS; MLH1; MUTATIONS; FAMILIES;
D O I
10.1038/gim.2017.37
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: The 2015 American College of Medical Genetics and Genomics-Association for Molecular Pathology (ACMG-AMP) guidelines were a major step toward establishing a common framework for variant classification. In practice, however, several aspects of the guidelines lack specificity, are subject to varied interpretations, or fail to capture relevant aspects of clinical molecular genetics. A simple implementation of the guidelines in their current form is insufficient for consistent and comprehensive variant classification. Methods: We undertook an iterative process of refining the ACMG-AMP guidelines. We used the guidelines to classify more than 40,000 clinically observed variants, assessed the outcome, and refined the classification criteria to capture exceptions and edge cases. During this process, the criteria evolved through eight major and minor revisions. Results: Our implementation: (i) separated ambiguous ACMG-AMP criteria into a set of discrete but related rules with refined weights; (ii) grouped certain criteria to protect against the overcounting of conceptually related evidence; and (iii) replaced the "clinical criteria" style of the guidelines with additive, semiquantitative criteria. Conclusion: Sherloc builds on the strong framework of 33 rules established by the ACMG-AMP guidelines and introduces 108 detailed refinements, which support a more consistent and transparent approach to variant classification.
引用
收藏
页码:1105 / 1117
页数:13
相关论文
共 51 条
[1]  
Ahn Kyung Jin, 2015, Korean J Pediatr, V58, P392, DOI 10.3345/kjp.2015.58.10.392
[2]   Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium [J].
Amendola, Laura M. ;
Jarvik, Gail P. ;
Leo, Michael C. ;
McLaughlin, Heather M. ;
Akkari, Yassmine ;
Amaral, Michelle D. ;
Berg, Jonathan S. ;
Biswas, Sawona ;
Bowling, Kevin M. ;
Conlin, Laura K. ;
Cooper, Greg M. ;
Dorschner, Michael O. ;
Dulik, Matthew C. ;
Ghazani, Arezou A. ;
Ghosh, Rajarshi ;
Green, Robert C. ;
Hart, Ragan ;
Horton, Carrie ;
Johnston, Jennifer J. ;
Lebo, Matthew S. ;
Milosavljevic, Aleksandar ;
Ou, Jeffrey ;
Pak, Christine M. ;
Patel, Ronak Y. ;
Punj, Sumit ;
Richards, Carolyn Sue ;
Salama, Joseph ;
Strande, Natasha T. ;
Yang, Yaping ;
Plon, Sharon E. ;
Biesecker, Leslie G. ;
Rehm, Heidi L. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 98 (06) :1067-1076
[3]   New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants [J].
Andreasen, Charlotte ;
Nielsen, Jonas B. ;
Refsgaard, Lena ;
Holst, Anders G. ;
Christensen, Alex H. ;
Andreasen, Laura ;
Sajadieh, Ahmad ;
Haunso, Stig ;
Svendsen, Jesper H. ;
Olesen, Morten S. .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (09) :918-928
[4]  
[Anonymous], 1999, GENEREVIEWS
[5]  
[Anonymous], 2002, GENEREVIEWS
[6]   Characterization of a Phenotype-Based Genetic Test Prediction Score for Unrelated Patients With Hypertrophic Cardiomyopathy [J].
Bos, J. Martijn ;
Will, Melissa L. ;
Gersh, Bernard J. ;
Kruisselbrink, Teresa M. ;
Ommen, Steve R. ;
Ackerman, Michael J. .
MAYO CLINIC PROCEEDINGS, 2014, 89 (06) :727-737
[7]   Hereditary breast cancer: new genetic developments, new therapeutic avenues [J].
Campeau, Philippe M. ;
Foulkes, William D. ;
Tischkowitz, Marc D. .
HUMAN GENETICS, 2008, 124 (01) :31-42
[8]   Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management [J].
Corso, G. ;
Roviello, F. ;
Paredes, J. ;
Pedrazzani, C. ;
Novais, M. ;
Correia, J. ;
Marrelli, D. ;
Cirnes, L. ;
Seruca, R. ;
Oliveira, C. ;
Suriano, G. .
EJSO, 2007, 33 (09) :1061-1067
[9]   A Clinical Approach to Inherited Hypertrophy The Use of Family History in Diagnosis, Risk Assessment, and Management [J].
Dunn, Kyla E. ;
Caleshu, Colleen ;
Cirino, Allison L. ;
Ho, Carolyn Y. ;
Ashley, Euan A. .
CIRCULATION-CARDIOVASCULAR GENETICS, 2013, 6 (01) :118-131
[10]   A systematic approach to assessing the clinical significance of genetic variants [J].
Duzkale, H. ;
Shen, J. ;
McLaughlin, H. ;
Alfares, A. ;
Kelly, M. A. ;
Pugh, T. J. ;
Funke, B. H. ;
Rehm, H. L. ;
Lebo, M. S. .
CLINICAL GENETICS, 2013, 84 (05) :453-463